Basal Ganglia Pathophysiology
131 – 140 of 197
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats.
- Contribution to journal › Article
-
Mark
Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
- Contribution to journal › Article
-
Mark
Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia.
- Contribution to journal › Article
-
Mark
Human dignity must be basis for debate on primate research
- Contribution to journal › Letter
-
Mark
Pathophysiology of L-DOPA-Induced Dyskinesia in Parkinson's Disease
(2009) p.434-444
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Dopamine replacement therapy in Parkinson´s Disease: past, present and future
(2009) p.309-334
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Rodent models of treatment-induced motor complications in Parkinson's disease
- Contribution to journal › Article
- 2008
-
Mark
Two routes for L-dopa to be converted to dopamine
(2008) 15th Annual Meeting of the American Society for Neural Therapy and Repair In Cell Transplantation 17(4). p.482-482
- Contribution to journal › Published meeting abstract
-
Mark
Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.
- Contribution to journal › Article
-
Mark
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation
- Contribution to journal › Article
